
    
      A Multicenter, Double-blind, Randomized, Parallel-group, Active Control Study to Compare the
      Efficacy, Safety, and Immunogenicity of AVT02 Versus HumiraÂ® in Patients with
      Moderate-to-Severe Chronic Plaque Psoriasis (ALVOPAD PS).

      This study will be conducted at about 40 study centers in central and eastern European
      countries. A contract research organization, will oversee operational aspects of this study
      on behalf of Alvotech Swiss AG (Alvotech), the Sponsor of the study.
    
  